MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ALXO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

ALX Oncology Holdings (ALXO) Ownership - Who owns ALX Oncology Holdings?

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
323 Allerton Avenue
Phone
+1 650 466-7125
Employees
43
Web
https://www.alxoncology.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
268.26M
P/E Ratio
N/A
Total Cash
138.23M
Projected Growth
N/A
Total Debt
9.71M
Revenue
N/A
Risk (Beta)
0.13
Dividend Yield
N/A
Total Cash/Share
1.00
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
ALXO
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for ALXO
A.I. Advisor
published General Information

General Information

a clinical stage company, which engages in the research and development of therapies for cancer patients

Industry Biotechnology

Profile
Details
Industry
N/A
Address
323 Allerton Avenue
Phone
+1 650 466-7125
Employees
43
Web
https://www.alxoncology.com
Who owns ALX Oncology Holdings? ALXO symbol Ownership - Tickeron.com